Nabriva Corporate
Go to...
  • Home
  • About Nabriva
    • Our Products
    • Named Patient Program
    • Meet the Team
  • pipeline & research
    • Fosfomycin
    • pleuromutilins
  • For Investors
    • Events & Presentations
    • Press Releases
    • Financial Performance
    • Share Performance
    • Shareholder Information
    • Corporate Governance
  • News & Publications
  • careers
  • contact us
  • Nabriva US
  • News & Publications
  • Careers
  • Contact Us
Nabriva Corporate
  • Home
  • About Nabriva
    • Our Products
    • Named Patient Program
    • Meet the Team
  • pipeline & research
    • Fosfomycin
    • pleuromutilins
  • For Investors
    • Events & Presentations
    • Press Releases
    • Financial Performance
    • Share Performance
    • Shareholder Information
    • Corporate Governance
  • News & Publications
  • careers
  • contact us

contact us

Home / contact us

Medical Information

For Product information or to report an adverse event, product quality complaint, or exposure to XENLETA during pregnancy:


1-855-5NABRIVA, Press 1 (MON-FRI:9AM-5PM EST)

Medical.Information@Nabriva.com

Suspected adverse events may be reported to the FDA directly

1-800-FDA-1088 or www.fda.gov/medwatch

Nabriva Therapeutics US, Inc.

414 Commerce Drive, Suite 120
Fort Washington, PA 19034
USA

View Google map

T +1 (610) 816-6640

F +1 (610) 816-6639

officeUS@nabriva.com

Nabriva Therapeutics GmbH

Leberstrasse 20
1110 Vienna
Austria

View Google map

T +43 (0)1 740 93-0

F +43 (0)1 740 93-1900

office@nabriva.com

FN 269261 Y

VAT No.: ATU62319422

Nabriva Therapeutics plc

25-28 North Wall Quay,
IFSC, Dublin 1, Ireland

T +353 1 649 2000

officeIE@nabriva.com

 

Nabriva Therapeutics Ireland DAC

Alexandra House, Office 225/227
The Sweepstakes
Ballsbridge
Dublin 4
D04 C7H2
Republic of Ireland

View Google map

T +353 (0) 1 664 1700

officeIE@nabriva.com

VAT No. 3514827BH

Reg. No. 612454

 

Press Contact

PR@nabriva.com

Business Development Contact

BD@nabriva.com

 

 

 

   
   
   
   
   
   

 

Nabriva logo
  • Privacy Notice
  • Accessibility Statement
  • Patents
  • Imprint
  • Disclaimer
  • Contact Us
  • Careers
  • Sitemap

© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 North Wall Quay, Dublin 1, Ireland

  • Privacy Notice
  • Accessibility Statement
  • Patents
  • Imprint
  • Disclaimer
  • Contact Us
  • Careers
  • Sitemap
Nabriva logo

© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 North Wall Quay, Dublin 1, Ireland